GREAT POINT PARTNERS LLC Quant / Systematic

Location: Greenwich, CT

CIK: 0001281446 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value: $415M (100.0% shares, 0.0% debt)

Holdings (40)

XENE XENON PHARMACEUTICALS INC 7.4%
Value $30.68M Shares 850,000 Est. Cost $22.27 Unrealized +61.5%
JAZZ JAZZ PHARMACEUTICALS PLC 6.9%
Value $28.66M Shares 215,000 Est. Cost $147.36 Unrealized +3.2%
POINT BIOPHARMA GLOBAL INC 6.6%
Value $27.53M Shares 3,560,984 Est. Cost $7.65 Unrealized
ALPINE IMMUNE SCIENCES INC 6.0%
Value $24.83M Shares 3,448,521 Est. Cost $7.40 Unrealized
TVTX TRAVERE THERAPEUTICS INC 5.7%
Value $23.8M Shares 966,108 Est. Cost $25.28 Unrealized +2.2%
HRTX HERON THERAPEUTICS INC 5.7%
Value $23.48M Shares 5,645,161 Est. Cost $3.91 Unrealized 0.0%
KALV KALVISTA PHARMACEUTICALS INC 5.4%
Value $22.52M Shares 1,551,719 Est. Cost $13.36 Unrealized +4.6%
PLRX PLIANT THERAPEUTICS INC 5.2%
Value $21.76M Shares 1,041,737 Est. Cost $14.77 Unrealized +29.6%
RLMD RELMADA THERAPEUTICS INC 4.5%
Value $18.88M Shares 510,000 Est. Cost $22.09 Unrealized +25.4%
ACRS ACLARIS THERAPEUTICS INC 3.9%
Value $16.04M Shares 1,019,282 Est. Cost $15.21 Unrealized +3.6%
PCVX VAXCYTE INC 3.5%
Value $14.4M Shares 600,000 Est. Cost $22.79 Unrealized +11.2%
GLPG GALAPAGOS NV 3.1%
Value $13.06M Shares 306,411 Est. Cost $56.28 Unrealized
ABOS ACUMEN PHARMACEUTICALS INC 2.9%
Value $12.04M Shares 1,200,000 Est. Cost $4.79 Unrealized +19.8%
ALKS ALKERMES PLC 2.7%
Value $11.33M Shares 507,500 Est. Cost $27.94 Unrealized -6.9%
SEAGEN INC 2.5%
Value $10.47M Shares 76,500 Est. Cost $136.82 Unrealized
BBIO BRIDGEBIO PHARMA INC 2.5%
Value $10.44M Shares 1,050,000 Est. Cost $10.39 Unrealized 0.0%
CINCOR PHARMA INC 2.4%
Value $9.889M Shares 301,324 Est. Cost $18.68 Unrealized
VTYX VENTYX BIOSCIENCES INC 2.3%
Value $9.425M Shares 269,967 Est. Cost $13.58 Unrealized +63.1%
TRICIDA INC 2.2%
Value $9.118M Shares 870,000 Est. Cost $4.49 Unrealized
RAPT THERAPEUTICS INC 1.8%
Value $7.579M Shares 315,000 Est. Cost $24.06 Unrealized
URGN UROGEN PHARMA LTD 1.7%
Value $7.267M Shares 873,424 Est. Cost $15.60 Unrealized -47.0%
REPL REPLIMUNE GROUP INC 1.6%
Value $6.735M Shares 390,000 Est. Cost $19.07 Unrealized 0.0%
MDGL MADRIGAL PHARMACEUTICALS INC 1.5%
Value $6.207M Shares 95,500 Est. Cost $69.48 Unrealized 0.0%
MIST MILESTONE PHARMACEUTICALS IN 1.5%
Value $6.2M Shares 674,656 Est. Cost $7.58 Unrealized 0.0%
89BIO INC 1.3%
Value $5.529M Shares 955,000 Est. Cost $3.22 Unrealized
GENERATION BIO CO 1.1%
Value $4.381M Shares 825,077 Est. Cost $5.31 Unrealized
NGM BIOPHARMACEUTICALS INC 1.0%
Value $4.137M Shares 316,256 Est. Cost $13.08 Unrealized
MLTX MOONLAKE IMMUNOTHERAPEUTICS 0.9%
Value $3.818M Shares 492,000 Est. Cost $6.38 Unrealized +10.4%
IMCR IMMUNOCORE HLDGS PLC 0.9%
Value $3.686M Shares 78,527 Est. Cost $46.94 Unrealized
LRMR LARIMAR THERAPEUTICS INC 0.9%
Value $3.632M Shares 1,135,000 Est. Cost $2.51 Unrealized 0.0%
PRECISION BIOSCIENCES INC 0.8%
Value $3.524M Shares 2,710,805 Est. Cost $1.60 Unrealized
CYMABAY THERAPEUTICS INC 0.7%
Value $2.798M Shares 799,439 Est. Cost $3.50 Unrealized
PIERIS PHARMACEUTICALS INC 0.5%
Value $2.26M Shares 1,965,449 Est. Cost $3.35 Unrealized
INTERCEPT PHARMACEUTICALS IN 0.4%
Value $1.465M Shares 105,000 Est. Cost $13.95 Unrealized
GRACELL BIOTECHNOLOGIES INC 0.3%
Value $1.446M Shares 449,049 Est. Cost $3.22 Unrealized
MAGENTA THERAPEUTICS INC 0.3%
Value $1.437M Shares 1,019,091 Est. Cost $9.65 Unrealized
NEKTAR THERAPEUTICS 0.3%
Value $1.433M Shares 447,820 Est. Cost $3.80 Unrealized
DAWN DAY ONE BIOPHARMACEUTICALS I 0.3%
Value $1.415M Shares 70,621 Est. Cost $21.27 Unrealized 0.0%
AEGLEA BIOTHERAPEUTICS INC 0.3%
Value $1.315M Shares 2,500,000 Est. Cost $0.51 Unrealized
SLN SILENCE THERAPEUTICS PLC 0.2%
Value $692K Shares 68,915 Est. Cost $23.89 Unrealized